<DOC>
	<DOCNO>NCT00723112</DOCNO>
	<brief_summary>The purpose study elucidate causative molecular event responsible abnormal erythropoiesis MDS .</brief_summary>
	<brief_title>The Role Erythropoietin Myelodysplastic Syndrome</brief_title>
	<detailed_description>Myelodysplastic syndrome heterogeneous group disorder characterize clonal expansion hematopoietic stem cell ineffective hematopoiesis . Although 3 cell lineage myeloid hematopoiesis involve , erythroid dysplasia ineffective erythropoiesis MDS usually severe , often precede development bone marrow lineage defect . In normal erythropoiesis , erythroid progenitor differentiate proliferate response stimulation erythropoietin ( Epo ) . Epo bind receptor , EpoR , constitutively express surface commit erythroid progenitor induces homodimerization . This study design evaluate EpoR cDNA sequence level expression clonal erythroid progenitor MDS patient ( cell stratify degree erythroid maturation ) determine whether mutation EpoR may responsible aberrant Epo signal transduction MDS . As well analyze intrinsic erythroid Epo expression determine whether differs normal control patient MDS perform microarray analysis gene associate Epo signal transduction determine MDS patient abnormal expression signal transduction protein .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Adult subject great 18 year age Diagnosis MDS base FrenchAmericanBritish classification system ( include secondary cause MDS ) Subjects meet criterion list</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Myelodysplastic Syndrome</keyword>
	<keyword>Erythropoiesis</keyword>
	<keyword>Ineffective Hematopoiesis</keyword>
	<keyword>Erythroid Progenitors</keyword>
	<keyword>Dyserythropoiesis</keyword>
</DOC>